<code id='822EA95D4E'></code><style id='822EA95D4E'></style>
    • <acronym id='822EA95D4E'></acronym>
      <center id='822EA95D4E'><center id='822EA95D4E'><tfoot id='822EA95D4E'></tfoot></center><abbr id='822EA95D4E'><dir id='822EA95D4E'><tfoot id='822EA95D4E'></tfoot><noframes id='822EA95D4E'>

    • <optgroup id='822EA95D4E'><strike id='822EA95D4E'><sup id='822EA95D4E'></sup></strike><code id='822EA95D4E'></code></optgroup>
        1. <b id='822EA95D4E'><label id='822EA95D4E'><select id='822EA95D4E'><dt id='822EA95D4E'><span id='822EA95D4E'></span></dt></select></label></b><u id='822EA95D4E'></u>
          <i id='822EA95D4E'><strike id='822EA95D4E'><tt id='822EA95D4E'><pre id='822EA95D4E'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:8223
          microbiome runners
          Adobe

          Elite athletes really are different from you and me. Or, at least their gut microbes are.

          Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

          advertisement

          That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.  

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves
          Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

          MollyFerguson/STATThisweek,anencouragingturnaroundforOcularTherapeutix,achatwithAlnylam’sCEOdefendin

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Congenital heart disease patients face new threat of heart failure

          AdobeWhenJenniferCasewaslivinginLosAngelesinherearly30s,shewashospitalized11times.Shehadbeenbornwith